Boehringer Ingelheim: CT budget threatens upgrades

From left, Dr. James Baxter, senior vice president, Development of Boehringer Ingelheim Pharmaceuticals; Governor Dannel Malloy; Dr. Wolfgang Baiker, head, Global Development for the company and Albert Ros, former president and CEO of the pharmaceutical talk about planned improvements at their Ridgefield/Danbury campus during a meeting about four years ago. Photo: Contributed Photo RIDGEFIELD -- Boehringer Ingelheim executives on Wednesday warned at least $300 million in upgrades to its U.S. corporate campus could be in jeopardy if lawmakers in Hartford move forward with proposed tax increases on state businesses.

via http://ift.tt/1AOLeBB